Rohto Pharmaceutical Co.,Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RPHCF research report →
About the company
Rohto Pharmaceutical Co. ,Ltd. operates as a global enterprise, specializing in the manufacturing and distribution of pharmaceuticals, cosmetics, and health-enhancing functional foods.
- CEO
- Hidetoshi Segi
- IPO
- 2010
- Employees
- 7,259
- HQ
- Osaka, JP
Price Chart
- Market Cap
- $3.39B
- P/E
- 15.87
- P/S
- 1.58
- P/B
- 1.80
- EV/EBITDA
- 7.90
- Div Yield
- 1.91%
- Gross Margin
- 55.46%
- Op Margin
- 11.84%
- Net Margin
- 9.96%
- ROE
- 12.11%
- ROIC
- 7.61%
- Revenue
- $345.89B · 12.07%
- Net Income
- $34.46B · 11.15%
- EPS
- $151.79 · 11.52%
- Op Income
- $40.96B
- FCF YoY
- 38.57%
- 52W High
- $16.30
- 52W Low
- $14.34
- 50D MA
- $15.06
- 200D MA
- $15.42
- Beta
- -0.46
- Avg Volume
- 2
Get TickerSpark's AI analysis on RPHCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our RPHCF coverage
Recent articles, reports, and earnings notes.
No research on RPHCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RPHCF report →Similar companies
Peers in the same neighborhood.